Takeda Pharmaceutical Co. Ltd. - Interest Expense

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Interest-Expense" stands at 272.22 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2021.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 83.14 Billion JPY for the item "Interest Expense" represents a decrease of -22.42 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 83.14 Billion JPY for the item "Interest Expense" represents an increase of 21.45 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 272.22 Billion JPY for the item "Interest Expense" represents an increase of 5.70 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.18 percent compared to the value the year prior.
The 1 year change in percent is 12.18.
The 3 year change in percent is 52.04.
The 5 year change in percent is 27.05.
The 10 year change in percent is 572.72.

The Serie's long term average value is 115.89 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 134.88 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +17,394.60%.
The Serie's change in percent from it's maximum value, on 06/30/2021, to it's latest available value, on 09/30/2025, is -0.233%.